ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,444Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 1300

$406K Total Retail Price of All Prescriptions

Rank: 66 out of 1300

301 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 301 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,966 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LISINOPRIL 308 231 1 2
OMEPRAZOLE 270 223 2 4
FUROSEMIDE 250 193 3 8
HYDROCODONE-ACETAMINOPHEN 230 168 S3 4 5
LEVOTHYROXINE SODIUM 226 192 5 1
SIMVASTATIN 213 172 6 3
WARFARIN SODIUM 194 183 7 9
AMLODIPINE BESYLATE 179 150 8 6
POTASSIUM CHLORIDE 174 138 9 18
TAMSULOSIN HCL 172 167 10 25
CITALOPRAM HBR 140 130 11 19
METFORMIN HCL 130 92 12 7
HYDROCHLOROTHIAZIDE 122 110 13 10
ATORVASTATIN CALCIUM 119 112 14 13
GABAPENTIN 109 98 15 15
KLOR-CON M20 103 103 16 60
SERTRALINE HCL 103 68 16 26
ATENOLOL 101 78 18 12
ZOLPIDEM TARTRATE 97 41 19 14
FINASTERIDE 93 93 20 80
DIGOXIN 91 87 21 48
DONEPEZIL HCL 90 90 22 32
DIVALPROEX SODIUM 87 74 23 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 51 24 128
ALENDRONATE SODIUM 77 65 25 20
FENTANYL 75 41 S2 26 56
METOPROLOL TARTRATE 68 52 27 11
TRAZODONE HCL 67 48 28 34
CARVEDILOL 58 57 29 38
LOSARTAN POTASSIUM 57 46 30 16
PRAVASTATIN SODIUM 54 45 31 23
TRIAMCINOLONE ACETONIDE 53 44 32 122
TERAZOSIN HCL 52 39 33 52
BUSPIRONE HCL 52 50 33 166
POLYETHYLENE GLYCOL 3350 50 50 35 65
FLUTICASONE PROPIONATE 50 41 35 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.